相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。EuroInf: A Multicenter Comparative Observational Study of Apomorphine and Levodopa Infusion in Parkinson's Disease
Pablo Martinez-Martin et al.
MOVEMENT DISORDERS (2015)
Chronic nicotine attenuates phencyclidine-induced impulsivity in a mouse serial reaction time task
Daniel Scott et al.
BEHAVIOURAL BRAIN RESEARCH (2014)
Dopamine-Agonists and Impulsivity in Parkinson's Disease: Impulsive Choices vs. Impulsive Actions
Francesca Antonelli et al.
HUMAN BRAIN MAPPING (2014)
Genetics of preparation and response control in ADHD: the role of DRD4 and DAT1
Bjoern Albrecht et al.
JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY (2014)
Impulse control disorders in Parkinson's disease: decreased striatal dopamine transporter levels
Valerie Voon et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study
Pedro J. Garcia-Ruiz et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
for the LCIG Horizon Study Group. Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study (vol 13, pg 141, 2014)
C. W. Olen et al.
LANCET NEUROLOGY (2014)
Naltrexone for impulse control disorders in Parkinson disease A placebo-controlled study
Kimberly Papay et al.
NEUROLOGY (2014)
Depression and impulse control disorders in Parkinson's disease: Two sides of the same coin?
Chris Vriend et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2014)
Treatment of Cognitive, Psychiatric, and Affective Disorders Associated with Parkinson's Disease
Barbara Connolly et al.
NEUROTHERAPEUTICS (2014)
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
C. Warren Olanow et al.
LANCET NEUROLOGY (2014)
Managing impulse control behaviours in Parkinson's disease: practical guidelines
Graeme J. A. Macphee et al.
BRITISH JOURNAL OF HOSPITAL MEDICINE (2013)
Catechol-O-Methyltransferase Genotype Modulates Opioid Release in Decision Circuitry
Jennifer M. Mitchell et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2013)
Dopamine Agonist Withdrawal Syndrome: Implications for Patient Care
Melissa J. Nirenberg
DRUGS & AGING (2013)
Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic
Margarita Pondal et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Subthalamic nucleus stimulation and compulsive use of dopaminergic medication in Parkinson's disease
Alexandre Eusebio et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson's disease
Paolo Calabresi et al.
LANCET NEUROLOGY (2013)
Levodopa Infusion Improves Impulsivity and Dopamine Dysregulation Syndrome in Parkinson's Disease
Maria Jose Catalan et al.
MOVEMENT DISORDERS (2013)
Should Impulse Control Disorders and Dopamine Dysregulation Syndrome Be Indications for Deep Brain Stimulation and Intestinal Levodopa?
Michael S. Okun et al.
MOVEMENT DISORDERS (2013)
Prospective cohort study of impulse control disorders in Parkinson's disease
Jesse Bastiaens et al.
MOVEMENT DISORDERS (2013)
Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers
David Okai et al.
NEUROLOGY (2013)
Neurostimulation for Parkinson's Disease with Early Motor Complications
W. M. M. Schuepbach et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Impulse control disorders induced by rasagiline as adjunctive therapy for Parkinson's disease: Report of 2 cases
Carmine Vitale et al.
PARKINSONISM & RELATED DISORDERS (2013)
Daytime apomorphine infusion combined with transdermal Rotigotine patch therapy is tolerated at 2 years: A 24-h treatment option in Parkinson's disease
Antoniya Todorova et al.
BASAL GANGLIA (2013)
Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours
Eugenie Lhommee et al.
BRAIN (2012)
Opioid Antagonist Naltrexone for the Treatment of Pathological Gambling in Parkinson Disease
Domenico Bosco et al.
CLINICAL NEUROPHARMACOLOGY (2012)
Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: A [11C] FLB-457 and PET study
Nicola J. Ray et al.
NEUROBIOLOGY OF DISEASE (2012)
Transdermal rotigotine causes impulse control disorders in patients with restless legs syndrome
S. R. Schreglmann et al.
PARKINSONISM & RELATED DISORDERS (2012)
Identification of possible risk factors for the development of dopamine agonist withdrawal syndrome in Parkinson's disease
Anne-Louise Cunnington et al.
PARKINSONISM & RELATED DISORDERS (2012)
Relationships between deep brain stimulation and impulse control disorders in Parkinson's disease, with a literature review
P. Shotbolt et al.
PARKINSONISM & RELATED DISORDERS (2012)
Effects of STN and GPi Deep Brain Stimulation on Impulse Control Disorders and Dopamine Dysregulation Syndrome
Sarah J. Moum et al.
PLOS ONE (2012)
Cognitive-Behavioral Therapy for Pathological Gambling in Parkinson's Disease: A Pilot Controlled Study
Susana Jimenez-Murcia et al.
EUROPEAN ADDICTION RESEARCH (2012)
L-745,870 Reduces L-DOPA-Induced Dyskinesia in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Macaque Model of Parkinson's Disease
Philippe Huot et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Cognitive-Behavioral Therapy for Depression in Parkinson's Disease: A Randomized, Controlled Trial
Roseanne D. Dobkin et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease
Maria C. Rodriguez-Oroz et al.
BRAIN (2011)
Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours
Sean S. O'Sullivan et al.
BRAIN (2011)
Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats
L. Fattore et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Pathological gambling and the treatment of psychosis with aripiprazole: case reports
Neil Smith et al.
BRITISH JOURNAL OF PSYCHIATRY (2011)
Binge Eating in Parkinson's Disease: Prevalence, Correlates and the Contribution of Deep Brain Stimulation
Laura B. Zahodne et al.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2011)
Fatty Acid Amide Hydrolase (FAAH) Inhibition Reduces L-3,4-Dihydroxyphenylalanine-Induced Hyperactivity in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Lesioned Non-Human Primate Model of Parkinson's Disease
Tom H. Johnston et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Multiple impulse control disorders developing in Parkinson's disease after initiation of amantadine
R.A. Walsh et al.
MOVEMENT DISORDERS (2011)
The Selective Mu-Opioid Receptor Antagonist ADL5510 Reduces Levodopa-Induced Dyskinesia Without Affecting Antiparkinsonian Action in MPTP-Lesioned Macaque Model of Parkinson's Disease
James B. Koprich et al.
MOVEMENT DISORDERS (2011)
Amantadine Use Associated with Impulse Control Disorders in Parkinson Disease in Cross-Sectional Study
Daniel Weintraub et al.
ANNALS OF NEUROLOGY (2010)
Pathological Gambling in Parkinson Disease Is Reduced by Amantadine
Astrid Thomas et al.
ANNALS OF NEUROLOGY (2010)
Dopamine Agonist Withdrawal Syndrome in Parkinson Disease
Christina A. Rabinak et al.
ARCHIVES OF NEUROLOGY (2010)
Impulse Control Disorders in Parkinson Disease A Cross-Sectional Study of 3090 Patients
Daniel Weintraub et al.
ARCHIVES OF NEUROLOGY (2010)
Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation
Stephane Thobois et al.
BRAIN (2010)
Orally Disintegrating Selegiline in Parkinson Patients With Dopamine Agonist-Related Adverse Effects
Kelly E. Lyons et al.
CLINICAL NEUROPHARMACOLOGY (2010)
The dopamine D3 receptor antagonist, S33138, counters cognitive impairment in a range of rodent and primate procedures
Mark J. Millan et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
Reduction of L-DOPA-Induced Dyskinesia by the Selective Metabotropic Glutamate Receptor 5 Antagonist 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]pyridine in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Lesioned Macaque Model of Parkinson's Disease
Tom H. Johnston et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial
Adrian Williams et al.
LANCET NEUROLOGY (2010)
Clozapine for Medication-Related Pathological Gambling in Parkinson Disease
Alessandro Rotondo et al.
MOVEMENT DISORDERS (2010)
Mechanisms Underlying Dopamine-Mediated Reward Bias in Compulsive Behaviors
Valerie Voon et al.
NEURON (2010)
Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study
T. D. L. Steeves et al.
BRAIN (2009)
Subthalamic deep brain stimulation and impulse control in Parkinson's disease
T. D. Halbig et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients With Advanced Parkinson Disease A Randomized Controlled Trial
Frances M. Weaver et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease
Shen-Yang Lim et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2009)
alpha(1)-Adrenoceptors Mediate Dihydroxyphenylalanine-Induced Activity in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Lesioned Macaques
N. P. Visanji et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Managing Pathological Gambling in Parkinson's Disease with Enteral Levodopa/Carbidopa Infusions
Willi Gerschlager et al.
MOVEMENT DISORDERS (2009)
Impulsive and Compulsive Behaviors in Parkinson's Disease
Andrew H. Evans et al.
MOVEMENT DISORDERS (2009)
Rapid resolution of dopamine dysregulation syndrome (DDS) after subthalamic DBS for Parkinson disease (PD) - A case report
David Knobel et al.
COGNITIVE AND BEHAVIORAL NEUROLOGY (2008)
Olanzapine in the treatment of pathological gambling: A negative randomized placebo-controlled trial
Susan L. McElroy et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
Manic episode with psychotic symptoms in a patient with Parkinson's disease treated by subthalamic nucleus stimulation:: Improvement on switching the target
Delphine Raucher-Chene et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study
Pedro J. Garcia Ruiz et al.
MOVEMENT DISORDERS (2008)
The application of the 5-choice serial reaction time task for the assessment of visual attentional processes and impulse control in rats
Andrea Bari et al.
NATURE PROTOCOLS (2008)
Continuous dopaminergic stimulation - From theory to clinical practice
Angelo Antonini
PARKINSONISM & RELATED DISORDERS (2007)
Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior
Luc Mallet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease
H. M. M. Smeding et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Using STN DBS and medication reduction as a strategy to treat pathological gambling in Parkinson's disease
Fabio Bandini et al.
PARKINSONISM & RELATED DISORDERS (2007)
Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease
Joseph H. Friedman et al.
MOVEMENT DISORDERS (2006)
Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation
Claire Ardouin et al.
MOVEMENT DISORDERS (2006)
A randomized trial of deep-brain stimulation for Parkinson's disease
Guenther Deuschl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Hypomania as an adverse effect of subthalamic nucleus stimulation: report of two cases
T. S. Mandat et al.
ACTA NEUROCHIRURGICA (2006)
Addiction in Parkinson's disease: Impact of subthalamic nucleus deep brain stimulation
T Witjas et al.
MOVEMENT DISORDERS (2005)
The hippocampal-VTA loop: Controlling the entry of information into long-term memory
JE Lisman et al.
NEURON (2005)
Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy
KJ Klos et al.
PARKINSONISM & RELATED DISORDERS (2005)
Explosive-aggressive behavior related to bilateral subthalamic stimulation
M Sensi et al.
PARKINSONISM & RELATED DISORDERS (2004)
Mania following deep brain stimulation for Parkinson's disease
J Kulisevsky et al.
NEUROLOGY (2002)
Transient mania with hypersexuality after surgery for high-frequency stimulation of the subthalamic nucleus in Parkinson's disease
LM Romito et al.
MOVEMENT DISORDERS (2002)
Olanzapine in the treatment of dopamimetic-induced psychosis in patients with Parkinson's disease
A Breier et al.
BIOLOGICAL PSYCHIATRY (2002)
Reversible transvestic fetishism in a man with Parkinson's disease treated with selegiline
DE Riley
CLINICAL NEUROPHARMACOLOGY (2002)
Behavioural disorders, Parkinson's disease and subthalamic stimulation
JL Houeto et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2002)
Mirthful laughter induced by subthalamic nucleus stimulation
P Krack et al.
MOVEMENT DISORDERS (2001)
分享论文
